Your search returned 39 results.

Results
	1.	Can costs of hemophilia products be curtailed? Not as we do business today! [electronic resource] by Aledort, Louis M Producer: 20030703 In: Thrombosis and haemostasis vol. 88 Availability: No items available. Save to lists Add to cart (remove)
	2.	Platelet bleeding disorders and approach to their management. [electronic resource] by Aledort, Louis M Producer: 20060302 In: Current hematology reports vol. 4 Availability: No items available. Save to lists Add to cart (remove)
	3.	Treatment of factor XI deficiency. [electronic resource] by Aledort, Louis M Producer: 20110919 In: Clinical advances in hematology & oncology : H&O vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	4.	The ongoing imperative for immune tolerance induction in inhibitor management. [electronic resource] by Aledort, Louis M Producer: 20190813 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Deaths Associated with Emicizumab in Patients with Hemophilia A. [electronic resource] by Aledort, Louis M Producer: 20191122 In: The New England journal of medicine vol. 381 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: are they appropriate and safe? [electronic resource] by Aledort, Louis M Producer: 20040122 In: The Journal of thoracic and cardiovascular surgery vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Expert Review of Hematology: addressing the needs of a broad research field. [electronic resource] by Aledort, Louis M Producer: 20110412 In: Expert review of hematology vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Off-label use of recombinant activated factor VII--safe or not safe? [electronic resource] by Aledort, Louis M Producer: 20101112 In: The New England journal of medicine vol. 363 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Emicizumab in Hemophilia A. Reply. [electronic resource] by Aledort, Louis M Producer: 20200224 In: The New England journal of medicine vol. 382 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Why thrombin generation? From bench to bedside. [electronic resource] by Aledort, Louis M Producer: 20040415 In: Pathophysiology of haemostasis and thrombosis vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Do we need a better test? Can thrombin generation be useful? [electronic resource] by Aledort, Louis M Producer: 20040520 In: Current hematology reports vol. 3 Availability: No items available. Save to lists Add to cart (remove)
	12.	Orthopedic outcome studies and cost issues. [electronic resource] by Aledort, Louis M Producer: 20030911 In: Seminars in thrombosis and hemostasis vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Can managed care support hemophilia in the 21st century? [electronic resource] by Aledort, Louis M Coates, James Producer: 20050816 In: American journal of hematology vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	FEIBA: a prohemostatic agent. [electronic resource] by Cromwell, Caroline Aledort, Louis M Producer: 20121003 In: Seminars in thrombosis and hemostasis vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	United States' factor XI-deficiency patients need a safer treatment. [electronic resource] by Aledort, Louis M Goudemand, Jenny Producer: 20060223 In: American journal of hematology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody. [electronic resource] by Monahan, Paul E Aledort, Louis M Producer: 20050118 In: American journal of hematology vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate. [electronic resource] by Elliott, Brian M Aledort, Louis M Producer: 20131211 In: Expert review of hematology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Emicizumab Prophylaxis in Hemophilia A with Inhibitors. [electronic resource] by Aledort, Louis M Ewenstein, Bruce M Producer: 20171201 In: The New England journal of medicine vol. 377 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Advances in clotting factor treatment for congenital hemorrhagic disorders. [electronic resource] by Tarantino, Michael D Aledort, Louis M Producer: 20070914 In: Clinical advances in hematology & oncology : H&O vol. 2 Availability: No items available. Save to lists Add to cart (remove)
	20.	Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. [electronic resource] by Mayer, Sebastian A Aledort, Louis M Producer: 20050712 In: The Mount Sinai journal of medicine, New York vol. 72 Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 39 results.